Northern Financial Advisors Inc Buys Shares of 754 The Cigna Group (NYSE:CI)

Northern Financial Advisors Inc purchased a new position in shares of The Cigna Group (NYSE:CI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 754 shares of the health services provider’s stock, valued at approximately $208,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Prospera Private Wealth LLC acquired a new stake in The Cigna Group during the 3rd quarter worth approximately $37,000. Collier Financial purchased a new stake in shares of The Cigna Group during the fourth quarter worth $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group in the fourth quarter valued at $34,000. Harbor Capital Advisors Inc. purchased a new position in The Cigna Group in the third quarter valued at $45,000. Finally, Heck Capital Advisors LLC acquired a new position in The Cigna Group during the 4th quarter worth $53,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the topic of a number of analyst reports. Truist Financial reduced their price target on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Tuesday, February 4th. Cantor Fitzgerald reduced their target price on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Wells Fargo & Company lowered their price target on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a report on Tuesday, February 4th. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective on the stock. in a research report on Thursday, February 6th. Finally, Morgan Stanley decreased their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $373.69.

The Cigna Group Price Performance

Shares of NYSE CI opened at $299.99 on Friday. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a market cap of $83.44 billion, a P/E ratio of 24.51, a P/E/G ratio of 0.94 and a beta of 0.54. The stock has a 50 day moving average of $287.42 and a two-hundred day moving average of $321.61. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the company posted $6.79 earnings per share. On average, research analysts forecast that The Cigna Group will post 29.8 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.01%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio (DPR) is currently 45.75%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.